Johnson & Johnson

NYSE: JNJ
$150.47
-$1.89 (-1.2%)
Closing Price on December 4, 2024

JNJ Stock Chart and Intraday Price

JNJ Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 390,509.79M USD
Shares Outstanding 2,408,770,000
Johnson & Johnson is a global healthcare giant founded in 1886, headquartered in New Brunswick, New Jersey. It operates in the healthcare sector, offering a wide range of products across various therapeutic areas including immunology, infectious diseases, neuroscience, oncology, cardiovascular, and metabolism. Additionally, it has a MedTech segment that provides interventional solutions, orthopaedics, surgery technologies, contact lenses, and intraocular lenses. The company's products are distributed worldwide to retailers, wholesalers, hospitals, and healthcare professionals, emphasizing its commitment to improving health for people everywhere.

JNJ Articles

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Donald Trump’s victory is positive for the stock...
Dividend Aristocrats represent a wide range of stocks in different industries, but each of these companies holds one characteristic in common: their management teams have raised their dividend...
24/7 Wall St. Insights This election could be one of the closest in our history. Dividend stocks will remain popular regardless of who wins. Passive income is simple: own quality dividends that pay...
24/7 Wall St. Key Takeaways: SCHD is best suited for long-term investors seeking both income and growth potential, while SCHR appeals to conservative investors focused on safety and capital...
24/7 Wall Street Insights Dividend Kings are companies with an unbroken track record of dividend increases spanning a minimum of 50 consecutive years. Some of these companies have been in business...
A dividend aristocrat is an S&P 500 stock that has raised its dividend annually for at least 25 years. These are typically the kinds of blue-chip stocks many fund managers with a dividend mandate...
Dividend stocks are among the top assets long-term investors want to consider when it comes to building a stable income-generating portfolio over time. Of course, bonds and other fixed income...
The Federal Reserve gave stock markets a huge shot in the arm as it delivered a sizeable 50 bps interest rate cut, far larger than many pundits were expecting. It wasn’t just stocks, which benefit...
24/7 Wall St. Insights The futures market has 100% priced in a 25-basis-point rate cut. The futures traders are also pricing in a 41% chance of a 50=basis-point cut. Passive income is simple- own...
The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence that propelled Nvidia (NASDAQ:NVDA) to the forefront of the industry. The...
If you’re just a bit more worried about a market sell-off going into the fourth quarter, you’re not alone. The market’s speedy recovery from the near-correction that began this July seems too...
24/7 Wall St. Insights Social Security is not enough to provide for a comfortable retirement. The Dividend Kings are the perfect choice for growth and income investors. Passive income is simple: own...
Investors have long sought to maximize gains by timing the market – buying low and selling high. However, success in trading, or investing over relatively short-term time frames, generally requires...
24/7 Wall St. Insights Stocks that consistently raise their dividends offer investors huge total return potential. Dividend stocks will become more popular as interest rates decline. Grab this free...